Sanofi (SNY) Interest Expenses (2009 - 2026)

Sanofi has disclosed Interest Expenses across 18 years of filings, most recently posting -$333.6 million for Q2 2026.

• In Q2 2026, Interest Expenses fell 99.13% year-over-year to -$333.6 million; the TTM figure through Jun 2026 stood at -$1.9 billion (down 3.66% YoY), while the FY2025 annual figure was $655.4 million, up 156.43% from the prior year.
• Interest Expenses came in at -$333.6 million for Q2 2026 at Sanofi, down from -$208.4 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of -$98.8 million in Q1 2022 to a low of -$1.4 billion in Q4 2023.
• Average Interest Expenses over 5 years is -$401.1 million, with a median of -$274.2 million recorded in 2024.
• Year-over-year, Interest Expenses sank 233.33% in 2023 and jumped 53.7% in 2025.
• Over 5 years, Interest Expenses stood at -$438.7 million in 2022, then sank by 217.11% to -$1.4 billion in 2023, then grew by 17.58% to -$1.1 billion in 2024, then soared by 42.84% to -$655.4 million in 2025, then jumped by 49.1% to -$333.6 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were -$333.6 million in Q2 2026, -$208.4 million in Q1 2026, and -$655.4 million in Q4 2025.